These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23324136)
1. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis. Santos JM; Bárcia RN; Simões SI; Gaspar MM; Calado S; Agua-Doce A; Almeida SC; Almeida J; Filipe M; Teixeira M; Martins JP; Graça L; Cruz ME; Cruz P; Cruz H J Transl Med; 2013 Jan; 11():18. PubMed ID: 23324136 [TBL] [Abstract][Full Text] [Related]
2. Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data. Martins JP; Santos JM; de Almeida JM; Filipe MA; de Almeida MV; Almeida SC; Água-Doce A; Varela A; Gilljam M; Stellan B; Pohl S; Dittmar K; Lindenmaier W; Alici E; Graça L; Cruz PE; Cruz HJ; Bárcia RN Stem Cell Res Ther; 2014 Jan; 5(1):9. PubMed ID: 24438697 [TBL] [Abstract][Full Text] [Related]
3. The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In Vivo. Miranda JP; Filipe E; Fernandes AS; Almeida JM; Martins JP; De la Fuente A; Abal M; Barcia RN; Cruz P; Cruz H; Castro M; Santos JM Cell Transplant; 2015; 24(5):865-77. PubMed ID: 24480602 [TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922 [TBL] [Abstract][Full Text] [Related]
5. Umbilical cord tissue-derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing. Bárcia RN; Santos JM; Teixeira M; Filipe M; Pereira ARS; Ministro A; Água-Doce A; Carvalheiro M; Gaspar MM; Miranda JP; Graça L; Simões S; Santos SCR; Cruz P; Cruz H Cytotherapy; 2017 Mar; 19(3):360-370. PubMed ID: 28040463 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing. Santos JM; Camões SP; Filipe E; Cipriano M; Barcia RN; Filipe M; Teixeira M; Simões S; Gaspar M; Mosqueira D; Nascimento DS; Pinto-do-Ó P; Cruz P; Cruz H; Castro M; Miranda JP Stem Cell Res Ther; 2015 May; 6(1):90. PubMed ID: 25956381 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925 [TBL] [Abstract][Full Text] [Related]
8. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis. Miranda JP; Camões SP; Gaspar MM; Rodrigues JS; Carvalheiro M; Bárcia RN; Cruz P; Cruz H; Simões S; Santos JM Front Immunol; 2019; 10():18. PubMed ID: 30804924 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia. Pereira AR; Mendes TF; Ministro A; Teixeira M; Filipe M; Santos JM; Bárcia RN; Goyri-O'Neill J; Pinto F; Cruz PE; Cruz HJ; Santos SC Stem Cell Res Ther; 2016 Sep; 7(1):145. PubMed ID: 27680210 [TBL] [Abstract][Full Text] [Related]
10. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Choudhery MS; Badowski M; Muise A; Harris DT Cytotherapy; 2013 Mar; 15(3):330-43. PubMed ID: 23318344 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Ma D; Xu K; Zhang G; Liu Y; Gao J; Tian M; Wei C; Li J; Zhang L Int Immunopharmacol; 2019 Sep; 74():105687. PubMed ID: 31295689 [TBL] [Abstract][Full Text] [Related]
13. High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources. Amati E; Perbellini O; Rotta G; Bernardi M; Chieregato K; Sella S; Rodeghiero F; Ruggeri M; Astori G Stem Cell Res Ther; 2018 Jan; 9(1):10. PubMed ID: 29338788 [TBL] [Abstract][Full Text] [Related]
14. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases. Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord. Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells. Mennan C; Garcia J; Roberts S; Hulme C; Wright K Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton's Jelly. Walecka I; Gil-Kulik P; Krzyżanowski A; Czop M; Galkowski D; Karwat J; Chomik P; Świstowska M; Kwaśniewska A; Bogucka-Kocka A; Kocki J Med Sci Monit; 2017 Apr; 23():1886-1895. PubMed ID: 28422936 [TBL] [Abstract][Full Text] [Related]
19. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Gong W; Han Z; Zhao H; Wang Y; Wang J; Zhong J; Wang B; Wang S; Wang Y; Sun L; Han Z Cell Transplant; 2012; 21(1):207-16. PubMed ID: 21929848 [TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]